Research

Cellular

Tirzepatide can cause acute hepatocellular liver injury in patients.

Clinicians should monitor liver function in patients using tirzepatide.

StrongSupportsmedium confidence
We report a case of a young, previously healthy female who developed acute hepatocellular liver injury several months after initiating tirzepatide therapy for weight loss.
Bayan Saeed AlQarni et al. · Annales d Endocrinologie · 2026

Why this rating

Based on the case report format which provides direct evidence.

Source

Acute liver injury associated with tirzepatide: An unexpected adverse event warranting clinical attention

Bayan Saeed AlQarni et al. · Annales d Endocrinologie · 2026

DOI 10.1016/j.ando.2026.102485

case_studyCited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →